Article
Inorganic Chemistry, Vol. 49, No. 8, 2010 3659
would be beneficial to the development of new or improved
function.
Experimental Section
General Methods. All reagents were purchased from com-
mercial sources and used as received, unless otherwise noted.
Solvents were sparged with argon and dried over columns
containing Q-5 and molecular sieves. Potassium hydride
(KH), as a 30% dispersion in mineral oil, was filtered with a
medium-porosity glass frit and washed five times each with
pentane and Et2O. The solid KH was dried under vacuum and
stored under an inert atmosphere. 1,2-Diphenylhydrazine
(DPH) was recrystallized from Et2O, dried under vacuum, and
stored under an inert atmosphere. 18O2 (99 atom % 18O) was
purchased from ICON Isotopes (Summit, NJ). Elemental ana-
lysis was accomplished at Robertson Microlit Laboratories
(Madison, NJ). The syntheses of H3bpaa and its intermediates
were carried out under a dinitrogen atmosphere. The syntheses
of metal complexes were conducted in a Vacuum Atmospheres,
Co., drybox under an argon atmosphere. N-[6-(Bromomethyl)-
2-pyridyl]pivalamide64 was prepared according to literature
methods with minor variations.
Figure 21. Proposed structure of compound I in cytochrome P450 (A)
and the relationship between the redox potential and pKa for a metal-oxo
species in the cleavage of a C-H bond in methane with BDEC-H = 104
kcal/mol (B).
Green was the first to suggest the importance of the
basicity of the oxo ligand in oxygenases.61 They have been
exploring the intermediates formed during turnover in
P450 compounds and proposed that the redox poten-
tials of the metal-oxo intermediates are much lower
than previously thought, thus limiting oxidative damage.
In his model, the lower redox potential in compound I,
the competent oxidizing species in P450 compounds
(Figure 21), is compensated for by the basicity of the
oxo ligand in compound II, the one-electron-reduced
form of compound I. Green further proposed that this
type of chemistry is possible because of thiolate ligation to
the iron center, which is supported by resonance Raman
studies. Our work described above supports this idea,
as do two recent reports on synthetic manganese-oxo62
and iron-oxo63 systems.
Preparative Methods. N-(4-Fluorophenyl)-2-bromoacetamide.
A solution of 4-fluoroaniline (5.00 mL, 52.1 mmol) and Et3N (8.5
mL, 61 mmol) in 50 mL of CH2Cl2 was cooled to 0 ꢀC with an ice
water bath. Bromoacetyl bromide (4.60 mL, 53.0 mmol) was
diluted with CH2Cl2 (∼50 mL) and added dropwise. The solution
was brought to room temperature and stirred overnight. The
solution was concentrated under reduced pressure to a solid,
dissolved in CHCl3, and washed with 2 M HCl (3 ꢀ 50 mL),
H2O (1 ꢀ 50 mL), and brine (1 ꢀ 50 mL). The organic layer was
dried over anhydrous sodium sulfate, filtered, and concentrated to
a solid under reduced pressure. The solid was triturated with
CH2Cl2 and dried under vacuum to afford 8.06 g (67%). Mp:
132-134 ꢀC. 1H NMR (500 MHz, CDCl3): δ 8.14 (1H, s, NH),
7.50 (2H, m, ArH), 7.06 (2H, m, ArH), 4.03 (2H, s, CH2). 13C
NMR (500 MHz, CDCl3): δ 164.7, 159.2, 157.3, 135.0, 121.0,
115.6, 115.4, 30.3. 19F NMR (400 MHz, CDCl3): δ 118.8.
Summary
It has been nearly 100 years since Werner first proposed the
significance of the secondary coordination sphere in transi-
tion-metal complexes. Unbeknownst to Werner were many
of the central components that define and control the
chemistry associated with this sphere. Some advances have
been made in determining the regulatory features for the
secondary coordination sphere, as highlighted in this Forum
Article. We know that secondary coordination spheres are
essential for the function of nearly all metalloproteins and
that similar characteristics can be designed into synthetic
metal complexes. Its importance is now obvious in the
chemistry associated with dioxygen binding and activation,
as illustrated with respiratory proteins, oxygenases, and
synthetic complexes. Yet, with all of the progress that has
been made, our utilization of the secondary coordination
sphere still lags far behind that of the primary sphere, in large
part because of our inability to manipulate the noncovalent
interactions that are needed within the secondary sphere.
Examples from our group and others showed that the design
of systems with rigid scaffolds allows the positioning of
functional groups to promote the formation of intramolecu-
lar H bonds while at the same time isolating metal centers in a
manner similar to what occurs within a protein active site.
These principles should be applicable to most chemical
systems using transition-metal ions and undoubtedly
Bis[N-[6-pivalamido-2-(pyridylmethyl)benzyl]]amine. A solu-
tion of N-[6-(bromomethyl)-2-pyridyl]pivalamide (6.11 g, 22.5
mmol), benzylamine (1.2 mL, 11 mmol), and Et3N (3.5 mL,
25 mmol) in 100 mL of THF was refluxed for 63 h. The solution
was cooled to room temperature, filtered, and concentrated
under reduced pressure to a yellow oil. The product was purified
by silica gel column chromatography using 2:3 hexanes/EtOAc
1
to yield 4.06 g (76%). Mp: 97-106 ꢀC. H NMR (500 MHz,
CDCl3): δ 8.10 (2H, d, J = 8.3 Hz, NHArH), 7.98 (2H, s, NH),
7.68 (2H, t, J = 7.9 Hz, NHArH), 7.39 (2H, d, J = 7.5 Hz,
NHArH), 7.32 (4H, m, ArH), 7.24 (1H, m, ArH), 3.68 (4H, s,
NHArCH2), 3.67 (2H, s, NCH2Ar), 1.32 (18H, s, C(CH3)3). 13
C
NMR (500 MHz, DMSO): δ 177.5, 158.4, 152.0, 139.1, 139.0,
129.1, 128.8, 127.5, 117.8, 112.9, 59.3, 58.2, 39.8, 27.4.
Bis[N-(6-pivalamido-2-pyridylmethyl)]amine. To a solution of
bis[N-[6-pivalamido-2-(pyridylmethyl)]benzyl]amine (5.54 g,
11.4 mmol) and cyclohexene (33.0 mL, 326 mmol) in 80 mL of
EtOH was added 20% Pd/C (0.284 g). The suspension was
refluxed overnight, cooled to room temperature, and filtered
through a pad of Celite. The filtrate was concentrated under
reduced pressure to a yellow solid, washed with Et2O, and then
dried under vacuum to afford 2.54 g (69%). Mp: 127-128 ꢀC.
1H NMR (500 MHz, CDCl3): δ 8.13 (2H, d, J = 8.3 Hz, ArH),
7.99 (2H, s, NHAr), 7.87 (2H, t, J = 7.9 Hz, ArH), 7.04 (2H, d,
J = 7.5 Hz, ArH), 3.86 (4H, s, ArCH2), 1.33 (18H, s, C(CH3)3).
13C NMR (500 MHz, CDCl3): δ 177.1, 157.8, 151.3, 138.8,
118.2, 112.1, 54.3, 39.9, 27.6.
(61) (a) Green, M. T.; Dawson, J. H.; Gray, H. B. Science 2004, 304, 1653–
165. (b) Green, M. T. Curr. Opin. Chem. Biol. 2009, 13, 84–88.
(62) Lansky, D. E.; Goldberg, D. P. Inorg. Chem. 2006, 45, 5119–5125.
(63) Sastri, C. V.; Lee, J.; Oh, K.; Lee, Y. J.; Lee, J.; Jackson, T. A.; Ray,
K.; Hirao, H.; Shin, W.; Halfen, J. A.; Kim, J.; Que, L., Jr.; Shaik, S.; Nam,
W. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 19181–19186.
(64) Harata, M.; Hasegawa, K.; Jitsukawa, K.; Masuda, H.; Einaga, H.
Bull. Chem. Soc., Jpn. 1998, 71, 1031–1038.